GGrantIndex
Sort

64,565 grants matching drug discovery

Combating Bacterial Drug Resistance by Targeting the Enzymes of Evolution

$2,224,684
Rahul Manu Kohli · University Of Pennsylvania · DP2 · FY2012 · GM

Discovery of Chemical Probes and Therapeutic Leads

$2,224,280
Joseph M Fox · University Of Delaware · P20 · FY2016 · GM

Mammalian Developmental Genetics and Stem Cells

$2,223,170
Heiner Westphal · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease

$2,222,688
Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

Costimulatory Mechanisms of Autoimmunity (Composite)

$2,220,927
David A. Hafler · Yale University · P01 · FY2010 · AI

Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease

$2,219,336
Jin Wang · Baylor College Of Medicine · U01 · FY2022 · AG

Institute for Clinical and Translational Research

$2,219,191
Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2016 · TR

Institute for Clinical and Translational Research

$2,219,191
Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2014 · TR

Institute for Clinical and Translational Research

$2,219,191
Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2015 · TR

SPORE in Breast Cancer

$2,218,149
Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2019 · CA

Assay development and screening for molecular targets and discovery

$2,217,555
Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Optimization of SHIP1 Inhibitors for the Treatment of Alzheimer's Disease

$2,217,438
Timothy I Richardson · Indiana University Indianapolis · U01 · FY2025 · AG

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,216,839
Harry Bernard Greenberg · Stanford University · UL1 · FY2009 · RR

Innovative technologies to transform antibiotic discovery. Project 1 Genomic applications to transform Gram-negative Antibiotic discovery

$2,214,724
Deborah T Hung · Broad Institute, Inc. · U19 · FY2023 · AI

COBRE: Eukaryotic Pathogens Innovation Center (EPIC)

$2,214,268
James Culvin Morris · Clemson University · P20 · FY2023 · GM

Comparative Biology of Tissue Repair, Regeneration and Aging

$2,213,519
Iain A. Drummond · Mount Desert Island Biological Lab · P20 · FY2022 · GM

Title: Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery, Evaluation and Development

$2,213,196
Doug Smallwood · Fisher Bioservices, Inc. · N02 · FY2018 · CA

Innovative technologies to transform antibiotic discovery. Project 1 Genomic applications to transform Gram-negative Antibiotic discovery

$2,212,100
Deborah T Hung · Broad Institute, Inc. · U19 · FY2020 · AI

Genomic and synthetic biology tools for expressing natural product gene clusters

$2,210,549
Ronald Wayne Davis · Stanford University · U01 · FY2015 · GM

COBRE: Eukaryotic Pathogens Innovation Center (EPIC)

$2,209,541
James Culvin Morris · Clemson University · P20 · FY2022 · GM

Host Pathogen Variation & TB Pathogenesis

$2,209,347
Thomas R Hawn · University Of Washington · U19 · FY2025 · AI

Technolgy Implementation

$2,209,301
Hanlee Ji · Stanford University · P01 · FY2013 · HG

Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy

$2,207,796
Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2012 · CA

IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design

$2,207,796
Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA

Genomic and synthetic biology tools for expressing natural product gene clusters

$2,207,718
Ronald Wayne Davis · Stanford University · U01 · FY2014 · GM